Article
Topical application of Cas9 ribonucleoproteins inhibits corneal neovascularization in a mouse model of alkali burn injury
2025-07-25
Abstract excerpt
<title>Abstract</title> <p> Corneal neovascularization is a sight-threatening condition for which current treatments such as anti-VEGF agents are limited by invasiveness and side effects. We present the first non-viral, CRISPR/Cas9-based gene therapy delivered via topical eye drops that penetrates the cornea and inhibits pathological neovascularization. Cas9 ribonucleoproteins (RNPs) targeting the <italic>Vegfa...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 3bbb56b5-2304-55bc-be8a-0125a9b7dd1b
- DOI
- 10.21203/rs.3.rs-7096816/v1
